首页> 外文期刊>Experimental and clinical transplantation >Sodium Nitrite Attenuates Hepatic Ischemia-Reperfusion Injury in Rats
【24h】

Sodium Nitrite Attenuates Hepatic Ischemia-Reperfusion Injury in Rats

机译:亚硝酸钠减轻大鼠肝缺血再灌注损伤

获取原文
           

摘要

Objectives: Nitrite as an alternative source of nitric oxide has been proposed, as it can mediate the protective response in the presence of ischemia or hypoxic conditions and inorganic nitrite can be reduced to nitric oxide by xanthine oxidoreductase. Here, we investigated whether pretreatment with sodium nitrite can attenuate liver damage in hepatic ischemia-reperfusion injury and identified the possible mechanism of nitrite reduction using 2-(4-carboxyphenyl)-4,5dihydro-4,4,5,5-tetramethyl-1H-imidazolyl-1-oxy-3oxide (C-PTIO), a nitric oxide scavenger, and allopurinol, a xanthine oxidoreductase inhibitor. Materials and Methods: In experiment 1, 30 male Sprague-Dawley rats were divided into 5 groups: (1) sham-operated; (2) hepatic ischemia-reperfusion injury; and (3-5) sodium nitrite administered intra-peritoneally 30 minutes before ischemia at 2.5, 25, and 250 μmol/kg, respectively. In experiment 2, 24 male Sprague-Dawley rats were divided into 4 groups: (1) hepatic ischemia-reperfusion injury; (2) sodium nitrite + hepatic ischemia-reperfusion injury; (3) C-PTIO + sodium nitrite + hepatic ischemia-reperfusion injury; and (4) allopurinol + sodium nitrite + hepatic ischemia-reperfusion injury. Sodium nitrite (25 μmol/kg) was then administered 30 minutes before hepatic ischemia, and C-PTIO or allopurinol was administered 5 minutes before sodium nitrite admi-nistration. Blood aspartate aminotransferase, alanine aminotransferase, hepatic tissue malondialdehyde, histologic changes, and expression of mitogen-activated protein kinase family members were evaluated. Results: Sodium nitrite limited serum elevation of alanine aminotransferase and aspartate aminotransferase induced by hepatic ischemia-reperfusion with a peak effect occurring at 25 μmol/kg sodium nitrite. Pre-treatment with allopurinol abolished the protective effect of sodium nitrite, and C-PTIO treatment attenuated the hepatoprotection of sodium nitrite in rats with hepatic ischemia-reperfusion injury. Liver malondialdehyde activity after ischemia-reperfusion decreased in sodium nitrite-treated rats. Sodium nitrite also prevented hepatic ischemia-reperfusion-induced c-Jun N-terminal kinase and extracellular signal-regulated kinase phosphorylation. Conclusions: Exogenous sodium nitrite had protective effects against hepatic ischemia-reperfusion injury. Catalytic reduction to nitric oxide and attenuation of hepatic ischemia-reperfusion is dependent on xanthine oxidoreductase.
机译:目的:已经提出亚硝酸盐作为一氧化氮的替代来源,因为它可以在缺血或缺氧条件下介导保护性反应,并且黄​​嘌呤氧化还原酶可以将无机亚硝酸盐还原为一氧化氮。在这里,我们调查了亚硝酸钠预处理是否可以减轻肝脏缺血再灌注损伤中的肝损害,并确定了使用2-(4-羧苯基)-4,5dihydro-4,4,5,5-tetramethyl-一氧化氮清除剂1H-咪唑基-1-氧基-3氧化物(C-PTIO)和黄嘌呤氧化还原酶抑制剂别嘌醇。材料与方法:在实验1中,将30只雄性Sprague-Dawley大鼠分为5组:(1)假手术; (2)肝缺血再灌注损伤;和(3-5)缺血前30分钟腹膜内分别以2.5、25和250μmol/ kg施用亚硝酸钠。在实验2中,将24只雄性Sprague-Dawley大鼠分成4组:(1)肝缺血-再灌注损伤; (2)亚硝酸钠+肝缺血再灌注损伤; (3)C-PTIO +亚硝酸钠+肝缺血再灌注损伤; (4)别嘌呤醇+亚硝酸钠+肝缺血-再灌注损伤。然后在肝缺血前30分钟给药亚硝酸钠(25μmol/ kg),在亚硝酸钠给药前5分钟给药C-PTIO或别嘌呤醇。评估了血液中的天冬氨酸转氨酶,丙氨酸转氨酶,肝组织丙二醛,组织学变化以及促分裂原活化蛋白激酶家族成员的表达。结果:亚硝酸钠限制了肝脏缺血再灌注诱导的丙氨酸氨基转移酶和天冬氨酸氨基转移酶的血清升高,峰值效应出现在25μmol/ kg亚硝酸钠处。别嘌呤醇的预处理取消了亚硝酸钠的保护作用,而C-PTIO处理则减弱了肝缺血再灌注损伤大鼠的亚硝酸钠对肝脏的保护作用。亚硝酸钠处理的大鼠缺血再灌注后肝丙二醛活性降低。亚硝酸钠还阻止了肝缺血-再灌注诱导的c-Jun N-末端激酶和细胞外信号调节激酶的磷酸化。结论:外源亚硝酸钠对肝缺血再灌注损伤具有保护作用。催化还原成一氧化氮和减轻肝脏缺血-再灌注取决于黄嘌呤氧化还原酶。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号